IFG Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

IFG Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,261	Closed	-$241K	–	463
2022 Q1	$241K	Buy	5,261 +167	+3%	+$7.96K	0.02%	441
2021 Q4	$312K	Buy	5,094 +577	+13%	+$39.9K	0.03%	397
2021 Q3	$337K	Buy	4,517 +1,245	+38%	+$104K	0.04%	374
2021 Q2	$302K	Sell	3,272 -45	-1%	-$3.83K	0.03%	390
2021 Q1	$294K	Buy	+3,317	New	+$329K	0.04%	396

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

IFG Advisory's ARKG Position: Q2 2022 in Review

IFG Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,261 shares — an estimated $241K sold.

IFG Advisory first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $337K in Q3 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

IFG Advisory reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
IFG Advisory sold 5,261 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $241K.
IFG Advisory first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
IFG Advisory's ARK Genomic Revolution ETF position peaked at $337K in Q3 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on IFG Advisory's 13F filing for Q2 2022, filed 4 Aug 2022.